Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation ChimeraStem CellsBone Marrow TransplantationGraft vs Leukemia EffectMyeloablative AgonistsTissue DonorsBusulfanTreatment OutcomeRemission InductionVidarabineHematopoietic Stem CellsRecurrenceGraft vs Tumor EffectHistocompatibility TestingGraft SurvivalLymphocyte TransfusionLeukemiaLeukemia, Myeloid, AcuteImmunosuppressive AgentsMultiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRetrospective StudiesCord Blood Stem Cell TransplantationSiblingsWhole-Body IrradiationCombined Modality TherapyMinor Histocompatibility AntigensCytomegalovirus InfectionsSalvage TherapyDisease-Free SurvivalMyelodysplastic SyndromesLymphocyte DepletionSurvival AnalysisAntilymphocyte SerumLiver TransplantationVirus ActivationHistocompatibilitySurvival RateNeoplasm, ResidualPrecursor Cell Lymphoblastic Leukemia-LymphomaChimerismMelphalanHepatic Veno-Occlusive DiseaseTime FactorsAntigens, CD34T-LymphocytesHematopoietic Stem Cell MobilizationMesenchymal Stem Cell TransplantationCyclophosphamideCytomegalovirusAntineoplastic Combined Chemotherapy ProtocolsAcute DiseasePrimary MyelofibrosisAnemia, AplasticCell TransplantationHLA AntigensEmbryonic Stem CellsHematologic DiseasesFollow-Up StudiesKidney TransplantationLeukemia, Myeloid, Accelerated PhasePrognosisFusion Proteins, bcr-ablLeukemia, MyeloidTransplantation ImmunologyBone Marrow CellsRoseolovirus InfectionsBenzamidesImmunosuppressionAntibodies, NeoplasmCytarabineAdult Stem CellsLymphoproliferative DisordersAntineoplastic AgentsCell DifferentiationImmunocompromised HostPyrimidinesHematopoiesisHodgkin DiseaseReceptors, Purinergic P2X5Granulocyte Colony-Stimulating FactorFlow CytometryGraft RejectionNuclear FamilyPiperazinesLymphoma, Non-HodgkinGanciclovirInfectionCyclosporineBone MarrowImmunotherapy, AdoptiveFatal Outcome